Dr. Steven Andrew Wisel, MD

Dr. Wisel practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Wisel's NPI, 1689931818, was assigned on April 12, 2012. Dr. Wisel graduated from University of Illinois College of Medicine - Chicago in 2012. Dr. Wisel holds California license A128350.

Dr. Wisel's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Wisel's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Wisel to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wisel practices, 4 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Wisel's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. Wisel is board certified in surgery by the American Board of Surgery. Dr. Wisel is licensed in California.

CMS data shows 134 Medicare services from Dr. Wisel across 4 procedure codes in 2024, for 59 Medicare patients. Medicare paid $61,902 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 59 Medicare patients who saw Dr. Wisel in 2024. The largest group is 65 to 74, with 29 patients. 75% of them have chronic kidney disease, and 75% have diabetes. 53% are also on Medicaid. Their average risk score is 9.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wisel's median patient age at 57, with 39% women.

In 2024, Dr. Wisel wrote 67 Medicare Part D claims. 91% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $23 in total drug cost. In 2023, CMS named 124 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Wisel for performance year 2024, reported as part of a group. Dr. Wisel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 27 papers to Dr. Wisel, published from 2016 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Tissue and Organ Procurement, Tissue Donors and Graft Survival. Dr. Wisel has published most often in Am J Transplant. Dr. Wisel's most frequent co-authors are Justin A. Steggerda, MD, Irene K. Kim, MD and Garrett Richard Roll, MD.

CMS Open Payments shows 39 general payments to Dr. Wisel from 4 drug and device companies from 2022 to 2025. Travel and lodging make up the largest share, 46% of the total. Intuitive Surgical, Inc. paid the most, $8,848.

Dr. Wisel graduated from University of Illinois College of Medicine - Chicago in 2012.

Dr. Wisel is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.